Plasma coenzyme Q10 levels and postmenopausal breast cancer risk

The multiethnic cohort study

Weiwen Chai, Robert V. Cooney, Adrian A. Franke, Yurii B. Shvetsov, Christian P. Caberto, Lynne R. Wilkens, Loïc Le Marchand, Brian E. Henderson, Laurence N. Kolonel, Marc T. Goodman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Coenzyme Q10 (CoQ10) is a component of the mitochondrial electron transport chain and is considered an important cellular antioxidant. Decreased circulating CoQ10 levels have been reported in women with breast cancer, but evidence is limited. We examined the association of plasma CoQ10 levels with postmenopausal breast cancer risk using prospectively collected blood samples. Methods: Prediagnostic plasma levels of total CoQ10 were measured among 160 incident postmenopausal breast cancer cases and 289 controls in the Multiethnic Cohort Study. Cases and controls were individually matched on age, sex, ethnicity, study location (Hawaii or California), hormone replacement therapy use, date and time of specimen collection, and hours of fasting. Logistic regression was used to compute odds ratios and 95% confidence intervals. Results: Plasma CoQ10 levels were positively associated with breast cancer risk, overall (P = 0.04). The association was stronger after women diagnosed within 1 year of blood draw were excluded to eliminate possible preclinical cases (odds ratio for the highest versus the lowest tertile, 2.26; 95% confidence interval, 1.22-4.19; P for trend = 0.01). Conclusions: Higher CoQ10 levels in postmenopausal women may be associated with increased breast cancer risk. Impact: A potential role for CoQ10 in the development and progression of breast cancer has been postulated, but epidemiologic evidence is lacking. Findings from this prospective cohort study add to the limited literature, indicating the potential positive association of circulating CoQ10 with postmenopausal breast cancer risk.

Original languageEnglish (US)
Pages (from-to)2351-2356
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number9
DOIs
StatePublished - Sep 1 2010

Fingerprint

coenzyme Q10
Cohort Studies
Breast Neoplasms
Odds Ratio
Confidence Intervals
Specimen Handling
Hormone Replacement Therapy
Electron Transport

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Chai, W., Cooney, R. V., Franke, A. A., Shvetsov, Y. B., Caberto, C. P., Wilkens, L. R., ... Goodman, M. T. (2010). Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: The multiethnic cohort study. Cancer Epidemiology Biomarkers and Prevention, 19(9), 2351-2356. https://doi.org/10.1158/1055-9965.EPI-10-0396

Plasma coenzyme Q10 levels and postmenopausal breast cancer risk : The multiethnic cohort study. / Chai, Weiwen; Cooney, Robert V.; Franke, Adrian A.; Shvetsov, Yurii B.; Caberto, Christian P.; Wilkens, Lynne R.; Le Marchand, Loïc; Henderson, Brian E.; Kolonel, Laurence N.; Goodman, Marc T.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 19, No. 9, 01.09.2010, p. 2351-2356.

Research output: Contribution to journalArticle

Chai, W, Cooney, RV, Franke, AA, Shvetsov, YB, Caberto, CP, Wilkens, LR, Le Marchand, L, Henderson, BE, Kolonel, LN & Goodman, MT 2010, 'Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: The multiethnic cohort study', Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 9, pp. 2351-2356. https://doi.org/10.1158/1055-9965.EPI-10-0396
Chai, Weiwen ; Cooney, Robert V. ; Franke, Adrian A. ; Shvetsov, Yurii B. ; Caberto, Christian P. ; Wilkens, Lynne R. ; Le Marchand, Loïc ; Henderson, Brian E. ; Kolonel, Laurence N. ; Goodman, Marc T. / Plasma coenzyme Q10 levels and postmenopausal breast cancer risk : The multiethnic cohort study. In: Cancer Epidemiology Biomarkers and Prevention. 2010 ; Vol. 19, No. 9. pp. 2351-2356.
@article{c6dc47c3bfa34689b8b0c269d4a9e5cf,
title = "Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: The multiethnic cohort study",
abstract = "Background: Coenzyme Q10 (CoQ10) is a component of the mitochondrial electron transport chain and is considered an important cellular antioxidant. Decreased circulating CoQ10 levels have been reported in women with breast cancer, but evidence is limited. We examined the association of plasma CoQ10 levels with postmenopausal breast cancer risk using prospectively collected blood samples. Methods: Prediagnostic plasma levels of total CoQ10 were measured among 160 incident postmenopausal breast cancer cases and 289 controls in the Multiethnic Cohort Study. Cases and controls were individually matched on age, sex, ethnicity, study location (Hawaii or California), hormone replacement therapy use, date and time of specimen collection, and hours of fasting. Logistic regression was used to compute odds ratios and 95{\%} confidence intervals. Results: Plasma CoQ10 levels were positively associated with breast cancer risk, overall (P = 0.04). The association was stronger after women diagnosed within 1 year of blood draw were excluded to eliminate possible preclinical cases (odds ratio for the highest versus the lowest tertile, 2.26; 95{\%} confidence interval, 1.22-4.19; P for trend = 0.01). Conclusions: Higher CoQ10 levels in postmenopausal women may be associated with increased breast cancer risk. Impact: A potential role for CoQ10 in the development and progression of breast cancer has been postulated, but epidemiologic evidence is lacking. Findings from this prospective cohort study add to the limited literature, indicating the potential positive association of circulating CoQ10 with postmenopausal breast cancer risk.",
author = "Weiwen Chai and Cooney, {Robert V.} and Franke, {Adrian A.} and Shvetsov, {Yurii B.} and Caberto, {Christian P.} and Wilkens, {Lynne R.} and {Le Marchand}, Lo{\"i}c and Henderson, {Brian E.} and Kolonel, {Laurence N.} and Goodman, {Marc T.}",
year = "2010",
month = "9",
day = "1",
doi = "10.1158/1055-9965.EPI-10-0396",
language = "English (US)",
volume = "19",
pages = "2351--2356",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Plasma coenzyme Q10 levels and postmenopausal breast cancer risk

T2 - The multiethnic cohort study

AU - Chai, Weiwen

AU - Cooney, Robert V.

AU - Franke, Adrian A.

AU - Shvetsov, Yurii B.

AU - Caberto, Christian P.

AU - Wilkens, Lynne R.

AU - Le Marchand, Loïc

AU - Henderson, Brian E.

AU - Kolonel, Laurence N.

AU - Goodman, Marc T.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Background: Coenzyme Q10 (CoQ10) is a component of the mitochondrial electron transport chain and is considered an important cellular antioxidant. Decreased circulating CoQ10 levels have been reported in women with breast cancer, but evidence is limited. We examined the association of plasma CoQ10 levels with postmenopausal breast cancer risk using prospectively collected blood samples. Methods: Prediagnostic plasma levels of total CoQ10 were measured among 160 incident postmenopausal breast cancer cases and 289 controls in the Multiethnic Cohort Study. Cases and controls were individually matched on age, sex, ethnicity, study location (Hawaii or California), hormone replacement therapy use, date and time of specimen collection, and hours of fasting. Logistic regression was used to compute odds ratios and 95% confidence intervals. Results: Plasma CoQ10 levels were positively associated with breast cancer risk, overall (P = 0.04). The association was stronger after women diagnosed within 1 year of blood draw were excluded to eliminate possible preclinical cases (odds ratio for the highest versus the lowest tertile, 2.26; 95% confidence interval, 1.22-4.19; P for trend = 0.01). Conclusions: Higher CoQ10 levels in postmenopausal women may be associated with increased breast cancer risk. Impact: A potential role for CoQ10 in the development and progression of breast cancer has been postulated, but epidemiologic evidence is lacking. Findings from this prospective cohort study add to the limited literature, indicating the potential positive association of circulating CoQ10 with postmenopausal breast cancer risk.

AB - Background: Coenzyme Q10 (CoQ10) is a component of the mitochondrial electron transport chain and is considered an important cellular antioxidant. Decreased circulating CoQ10 levels have been reported in women with breast cancer, but evidence is limited. We examined the association of plasma CoQ10 levels with postmenopausal breast cancer risk using prospectively collected blood samples. Methods: Prediagnostic plasma levels of total CoQ10 were measured among 160 incident postmenopausal breast cancer cases and 289 controls in the Multiethnic Cohort Study. Cases and controls were individually matched on age, sex, ethnicity, study location (Hawaii or California), hormone replacement therapy use, date and time of specimen collection, and hours of fasting. Logistic regression was used to compute odds ratios and 95% confidence intervals. Results: Plasma CoQ10 levels were positively associated with breast cancer risk, overall (P = 0.04). The association was stronger after women diagnosed within 1 year of blood draw were excluded to eliminate possible preclinical cases (odds ratio for the highest versus the lowest tertile, 2.26; 95% confidence interval, 1.22-4.19; P for trend = 0.01). Conclusions: Higher CoQ10 levels in postmenopausal women may be associated with increased breast cancer risk. Impact: A potential role for CoQ10 in the development and progression of breast cancer has been postulated, but epidemiologic evidence is lacking. Findings from this prospective cohort study add to the limited literature, indicating the potential positive association of circulating CoQ10 with postmenopausal breast cancer risk.

UR - http://www.scopus.com/inward/record.url?scp=77956531073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956531073&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-10-0396

DO - 10.1158/1055-9965.EPI-10-0396

M3 - Article

VL - 19

SP - 2351

EP - 2356

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -